Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
Conditions
Interventions
Intervention1: Levobupivacaine administration: 0.375% Levobupivacaine that is 15 mL of 0.5% Levobupivacaine inn+ 5ml of NS is administered
Control Intervention1: Ropivacaine: 0.375% Ropivacaine that i
Sponsors
Vemulapalli Meghana
Eligibility
Inclusion criteria
Inclusion criteria: 1) ASA Grade 1 and 2 2) Forearm Surgeries
Exclusion criteria
Exclusion criteria: 1) Patient refusal 2) Local infection 3) Bleeding disorders 4) Coagulopathies 5) Allergic to local anesthetic agent 6) Patients with neuromuscular disorders and weakness and hemidiaphragmatic dysfunction 7) Patients with pre-existing cardiac and lung pathologies 8) Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The patients receiving Ropivacaine have less incidence of diaphragmatic dysfunction as compared to LevobupivacaineTimepoint: Assessment will be done at baseline, 15 minutes, 30 minutes and 2 hours after the block | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset of sensory blockadeTimepoint: Assessment done at regular intervals of one minute to determine time of onset of block;Onset of motor blockadeTimepoint: Assessment done at regular intervals of one minute to determine time of onset of block;Duration of analgesiaTimepoint: Assessment done at intervals of immediate post op, at 6 hours, 12 hours, 24 hours & 48 hours post op points | — |
Countries
India
Contacts
Public ContactVemulapalli Meghana
Nizam s Institute of Medical Sciences
Outcome results
None listed